Regulatory & Legal

With its runway extended by insiders, the biotech firm bets on its promising glioblastoma drug and an unconventional strategy of crypto and acquisitions.

An undisclosed Eastern European nation is deploying covert, AI-driven radar from UK's Blighter to counter rising geopolitical and hybrid threats.

OFAC's new license allows U.S. firms to trade Venezuelan gold, but a history of expropriation and illicit mining presents a high-stakes gamble for companies.

Ottawa is calling on Canadian industry to help maintain its next-generation submarines, a massive project testing a new national defence strategy.

Blue Owl's OBDC II faces a discounted activist bid, countering with a massive capital return plan. Shareholders must choose: cheap cash now or full value later?

Amid rising avian flu concerns, Canada secures millions of next-gen cell-based vaccines, upgrading its pandemic response arsenal for faster protection.

Justice Sherri Eisenpress establishes a $1,000 award for LGBTQ+ student leaders, blending a legacy of public service with a complex professional turning point.

Raising over $600k with CAF, recovery tech brand FIT KING makes a strategic push into adaptive sports, aiming to redefine performance and accessibility.

A landmark Urban Institute report confirms shared equity products offer a vital alternative to loans, fueling calls for a new consumer protection framework.

A Knights of Columbus convoy braved icy roads to bring record-breaking aid to a remote First Nations community recovering from devastating wildfires.

A landmark bill empowering parents with social media monitoring tools has passed a key hurdle, igniting a clash between safety, privacy, and Big Tech.

Tsakos Energy Navigation reports a 200% Q4 income jump, capitalizing on high tanker rates while investing in a new fleet of LNG and VLCC vessels.

The iconic fitness brand plans a major Brazil expansion, launches a new nutrition line, and returns to its roots in a bold push for its next era.

A new $175M 'cat bond' promises stability for homeowners in high-risk states, revealing the growing power of Wall Street in managing climate risk.

With a detailed M&A playbook, Standard Dental Labs aims to consolidate the dental lab industry. Can its disciplined strategy turn a micro-cap into a market leader?

With its key earnings call on March 12, Aemetis's recent tax credit sales and project milestones are weighed against past financial performance.

Artelo Biosciences executes a reverse stock split to fight delisting, but will the financial maneuver be enough to fund its promising drug pipeline?

Alpha Modus resolves its patent lawsuit against Brookshire Grocery, highlighting an aggressive IP strategy in the booming AI retail technology sector.

Allarity Therapeutics lands a crucial $20M debt deal to push its unique ovarian cancer drug, stenoparib, through late-stage trials and extend its runway to 2028.

AIRO Group will present its future vision at a major tech conference, facing investor scrutiny amid ambitious growth plans and recent financial hurdles.